By Dorothy Atkins ( January 10, 2023, 7:36 PM EST) -- The D.C. Circuit affirmed Tuesday the U.S. Food and Drug Administration's win in Sandoz Inc.'s lawsuit challenging the agency's decision to give rival Sanofi exclusivity to its multiple sclerosis drug, Aubagio, rejecting Sandoz's claim that the FDA already approved the drug's active ingredient as an impurity in another drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.